The pharmaceutical industry is changing at a rapid pace with a lot of trends and business relationships. This not only involves new medical developments, guidelines and corresponding equipment, but also the roles of all stakeholders. Uwe Harbauer, Senior Vice President of Bosch Packaging Technology’s Pharma Business Unit, shares his thoughts about the pharma marketing and relationships today.
Specializing in sterile manufacturing, Excelvision, based in Annonay, France, provides contract manufacturing services for liquid eye drop plastic vials to numerous companies. However, to increase production and capitalize on additional contract manufacturing opportunities, Excelvision enlised Bosch Packaging Systems AG, based in Beringen, Switzerland, to install a fully automated packaging line. With significantly higher output capabilities, Excelvision expects to increase production by nearly five-fold. The new line also gives the company greater flexibility to meet the diverse requirements of its customers.
Falsified medicines are fake medicines that pass themselves off as real, authorized medicines. They may contain ineffective or incorrect doses of active ingredients and pose a major threat to public health and safety. As falsifications become more sophisticated, the risk of falsified medicines reaching patients in the EU increases every year. Not only do falsified medicines present an incalculable health risk for patients, they also damage the corporate image of pharmaceutical manufacturers and can lead to large financial losses.
With the ever evolving developments in the biopharmaceutical Industry there has never been a greater need for assured Reliability when it comes to the transportation of Pharmaceutical payloads and the guaranteed robustness of Temperature-controlled packaging is proving ever more vital.
Your cold chain is about more than just protecting and delivering temperature-sensitive products. It is about caring for the lives affected by those products and protecting the environment we all share. Although many organizations still consider it challenging to find a packaging solution that is sustainable, affordable and operationally efficient for cold chain distribution, Cardinal Health knows differently.
The expanding global pharmaceutical industry projects a 4%-6% annual growth and forecasts that it will reach a value of $1T by 2014. By Paul Dupont
Blister packaging, not long ago considered a less significant segment of the North American pharmaceutical packaging industry, is now outpacing most other industry segments. In 2010, blister represented 17% of the global market and recorded $8.1B in revenue, according to Pharmaceutical Packaging Industry – 2011 Yearbook. GBI Research. By Paul Dupont, Director of Business Development North America, Ropack, Inc.